EUDAMED Deadline 2026 – 7 Steps Every MedTech Company Must Prepare

The upcoming EUDAMED deadline on May 28, 2026, marks a major shift in how regulatory data is managed under the EU MDR and IVDR.

While many companies believe this transition is simply about uploading documents into a European database, the reality is far more complex.

EUDAMED is not just a database — it is becoming the central regulatory infrastructure of the European medical device ecosystem, connecting manufacturers, notified bodies, regulators, and economic operators.

Why EUDAMED Matters

EUDAMED aims to increase:
• Transparency
• Traceability
• Post-market surveillance
• Regulatory oversight

To achieve this, companies must ensure that their internal data is structured, accurate, and aligned with regulatory expectations.

The Biggest Mistake

The most common misconception is treating EUDAMED as an IT project.

In reality, it is a data governance challenge.

Before uploading any device, companies must clearly define:
• Device families
• Basic UDI-DI and UDI-DI
• Certificate linkage
• Legal manufacturer responsibilities

Many organizations struggle with these fundamentals.

The 7-Step Readiness Checklist

To prepare effectively, QA/RA teams should focus on:

1. Actor registration (SRN)
2. Cleaning the device portfolio
3. Validating the UDI structure
4. Checking certificate data
5. Defining legacy device strategy
6. Assigning data ownership
7. Performing a dry run

Risks of Delayed Preparation

Companies that delay preparation may face:
• Incomplete or inconsistent data
• Registration delays
• Regulatory bottlenecks
• Internal confusion

EUDAMED could quickly become a regulatory traffic jam for unprepared organizations.

A Practical Timeline

To avoid these risks:

• Immediately: Audit all regulatory data
• Next 1–2 months: Validate UDI structure and device hierarchy
• Before the deadline: Perform a full readiness simulation

Final Takeaway

EUDAMED is not just a compliance requirement — it is a transformation of how regulatory information is managed in Europe.

Companies that prepare early will transition smoothly.
Those that wait may face significant delays and operational challenges.

Social Media to follow

• Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi
• Twitter: https://twitter.com/elazzouzim
• Pinterest: https://www.pinterest.com/easymedicaldevice
• Instagram: https://www.instagram.com/easymedicaldevice

The post EUDAMED Deadline 2026 – 7 Steps Every MedTech Company Must Prepare appeared first on Medical Device made Easy Podcast. hamza benafqir